UAB was a lead site in the testing of Kalydeco, the first drug to target the underlying genetic causes of cystic fibrosis.

Published in Focus on Patient Care

A UAB researcher has received a grant to study idiopathic pulmonary fibrosis.

An antibiotic can help reduce acute COPD attacks and improve quality of life, a new study shows.

Published in Focus on Patient Care

UAB is the first in the state to offer new procedure that uses thermal energy to help keep airways flowing freely.

Published in Focus on Patient Care
Page 2 of 2
Back to Top